Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 71

    1.

    Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA).

    Osorio A, Milne RL, Pita G, Peterlongo P, Heikkinen T, Simard J, Chenevix-Trench G, Spurdle AB, Beesley J, Chen X, Healey S; KConFab, Neuhausen SL, Ding YC, Couch FJ, Wang X, Lindor N, Manoukian S, Barile M, Viel A, Tizzoni L, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai P, Rennert G, Lejbkowicz F, Barnett-Griness O, Andrulis IL, Ozcelik H, Weerasooriya N; OCGN, Gerdes AM, Thomassen M, Cruger DG, Caligo MA, Friedman E, Kaufman B, Laitman Y, Cohen S, Kontorovich T, Gershoni-Baruch R, Dagan E, Jernström H, Askmalm MS, Arver B, Malmer B; SWE-BRCA, Domchek SM, Nathanson KL, Brunet J, Ramón Y Cajal T, Yannoukakos D, Hamann U; HEBON, Hogervorst FB, Verhoef S, García EG, Wijnen JT, van den Ouweland A; EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Cook J, Hodgson S, Morrison PJ, Douglas F, Godwin AK; GEMO, Sinilnikova OM, Barjhoux L, Stoppa-Lyonnet D, Moncoutier V, Giraud S, Cassini C, Olivier-Faivre L, Révillion F, Peyrat JP, Muller D, Fricker JP, Lynch HT, John EM, Buys S, Daly M, Hopper JL, Terry MB, Miron A, Yassin Y, Goldgar D; Breast Cancer Family Registry, Singer CF, Gschwantler-Kaulich D, Pfeiler G, Spiess AC, Hansen TV, Johannsson OT, Kirchhoff T, Offit K, Kosarin K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deißler H, Fiebig B, Varon-Mateeva R, Schaefer D, Froster UG, Caldes T, de la Hoya M, McGuffog L, Antoniou AC, Nevanlinna H, Radice P, Benítez J.

    Br J Cancer. 2009 Nov 17. [Epub ahead of print]PMID: 19920816 [PubMed - as supplied by publisher]Related articles

    2.

    Tumour Risks and Genotype-Phenotype-Proteotype Analysis in 358 Patients with Germline Mutations in SDHB and SDHD.

    Ricketts CJ, Forman JR, Rattenbury E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Ajith Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER.

    Hum Mutat. 2009 Oct 2. [Epub ahead of print]PMID: 19802898 [PubMed - as supplied by publisher]Related articles

    3.

    The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

    Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X; kConFab, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, Andrulis IL; OCGN, Domchek SM, Nathanson KL, Manoukian S, Radice P, Konstantopoulou I, Blanco I, Laborde AL, Durán M, Osorio A, Benitez J, Hamann U, Hogervorst FB, van Os TA, Gille HJ; HEBON, Peock S, Cook M, Luccarini C, Evans DG, Lalloo F, Eeles R, Pichert G, Davidson R, Cole T, Cook J, Paterson J, Brewer C; EMBRACE, Hughes DJ, Coupier I, Giraud S, Coulet F, Colas C, Soubrier F, Rouleau E, Bièche I, Lidereau R, Demange L, Nogues C, Lynch HT; GEMO, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Sutter C, Deissler H, Schaefer D, Froster UG; GC-HBOC, Aittomäki K, Nevanlinna H, McGuffog L, Easton DF, Chenevix-Trench G, Stoppa-Lyonnet D; Consortium of Investigators of Modifiers of BRCA1/2.

    Br J Cancer. 2009 Oct 20;101(8):1456-60. Epub 2009 Aug 25.PMID: 19707196 [PubMed - indexed for MEDLINE]Related articles

    4.

    Update on genetic predisposition to breast cancer.

    Ahmed M, Lalloo F, Evans DG.

    Expert Rev Anticancer Ther. 2009 Aug;9(8):1103-13.PMID: 19671030 [PubMed - in process]Related articles

    5.

    Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent.

    Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A.

    Cancer Epidemiol Biomarkers Prev. 2009 Aug;18(8):2318-24.PMID: 19661091 [PubMed - indexed for MEDLINE]Related articles

    6.

    Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

    Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Neuhausen SL, Ding YC, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Peissel B, Bonanni B, Viel A, Bernard L, Radice P, Szabo CI, Foretova L, Zikan M, Claes K, Greene MH, Mai PL, Rennert G, Lejbkowicz F, Andrulis IL, Ozcelik H, Glendon G; OCGN, Gerdes AM, Thomassen M, Sunde L, Caligo MA, Laitman Y, Kontorovich T, Cohen S, Kaufman B, Dagan E, Baruch RG, Friedman E, Harbst K, Barbany-Bustinza G, Rantala J, Ehrencrona H, Karlsson P, Domchek SM, Nathanson KL, Osorio A, Blanco I, Lasa A, Benítez J, Hamann U, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE; HEBON, Peock S, Cook M, Frost D, Oliver C, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Chu C, Eccles D, Cole T, Hodgson S; EMBRACE, Godwin AK, Stoppa-Lyonnet D, Buecher B, Léoné M, Bressac-de Paillerets B, Remenieras A, Caron O, Lenoir GM, Sevenet N, Longy M, Ferrer SF, Prieur F; GEMO, Goldgar D, Miron A, John EM, Buys SS, Daly MB, Hopper JL, Terry MB, Yassin Y; Breast Cancer Family Registry, Singer C, Gschwantler-Kaulich D, Staudigl C, Hansen TO, Barkardottir RB, Kirchhoff T, Pal P, Kosarin K, Offit K, Piedmonte M, Rodriguez GC, Wakeley K, Boggess JF, Basil J, Schwartz PE, Blank SV, Toland AE, Montagna M, Casella C, Imyanitov EN, Allavena A, Schmutzler RK, Versmold B, Engel C, Meindl A, Ditsch N, Arnold N, Niederacher D, Deissler H, Fiebig B, Suttner C, Schönbuchner I, Gadzicki D, Caldes T, de la Hoya M, Pooley KA, Easton DF, Chenevix-Trench G; CIMBA.

    Hum Mol Genet. 2009 Nov 15;18(22):4442-56. Epub 2009 Aug 5.PMID: 19656774 [PubMed - in process]Related articles

    7.

    Breast cancer susceptibility variants alter risks in familial disease.

    Latif A, Hadfield KD, Roberts SA, Shenton A, Lalloo F, Black GC, Howell A, Evans DG, Newman WG.

    J Med Genet. 2009 Jul 23. [Epub ahead of print]PMID: 19617217 [PubMed - as supplied by publisher]Related articles

    8.

    Addition of pathology and biomarker information significantly improves the performance of the Manchester scoring system for BRCA1 and BRCA2 testing.

    Evans DG, Lalloo F, Cramer A, Jones E, Knox F, Amir E, Howell A.

    J Med Genet. 2009 Jun 18. [Epub ahead of print]PMID: 19542080 [PubMed - as supplied by publisher]Related articles

    9.

    Risk-reducing surgery for ovarian cancer: outcomes in 300 surgeries suggest a low peritoneal primary risk.

    Evans DG, Clayton R, Donnai P, Shenton A, Lalloo F.

    Eur J Hum Genet. 2009 Nov;17(11):1381-5. Epub 2009 Apr 15.PMID: 19367322 [PubMed - in process]Related articles

    10.

    Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations.

    Barrow E, Robinson L, Alduaij W, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG.

    Clin Genet. 2009 Feb;75(2):141-9.PMID: 19215248 [PubMed - indexed for MEDLINE]Related articles

    11.

    No evidence that GATA3 rs570613 SNP modifies breast cancer risk.

    Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X; kConFab Investigators; AOCS Group; Swedish BRCA1 and BRCA2 Study Collaborators, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko YD, Heikkinen T, Aaltonen K, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu J, Peock S, Cook M, Platte R, Gareth Evans D, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FB, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TA, Gille HJ, Blok MJ; HEBON, Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Chenevix-Trench G; Breast Cancer Association Consortium and Consortium of Investigators of Modifiers of BRCA1/2.

    Breast Cancer Res Treat. 2009 Sep;117(2):371-9. Epub 2008 Dec 11.PMID: 19082709 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk reducing mastectomy: outcomes in 10 European centres.

    Evans DG, Baildam AD, Anderson E, Brain A, Shenton A, Vasen HF, Eccles D, Lucassen A, Pichert G, Hamed H, Moller P, Maehle L, Morrison PJ, Stoppat-Lyonnet D, Gregory H, Smyth E, Niederacher D, Nestle-Krämling C, Campbell J, Hopwood P, Lalloo F, Howell A.

    J Med Genet. 2009 Apr;46(4):254-8. Epub 2008 Nov 7.PMID: 18996907 [PubMed - indexed for MEDLINE]Related articles

    13.

    Impaired tamoxifen metabolism reduces survival in familial breast cancer patients.

    Newman WG, Hadfield KD, Latif A, Roberts SA, Shenton A, McHague C, Lalloo F, Howell S, Evans DG.

    Clin Cancer Res. 2008 Sep 15;14(18):5913-8.PMID: 18794105 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.

    Byrd LM, Shenton A, Maher ER, Woodward E, Belk R, Lim C, Lalloo F, Howell A, Jayson GC, Evans GD.

    Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1535-42.PMID: 18559571 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations.

    Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG.

    Clin Genet. 2008 Sep;74(3):233-42. Epub 2008 Jun 28.PMID: 18554281 [PubMed - indexed for MEDLINE]Related articles

    17.

    Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers.

    Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dørum A, Steel M, Lalloo F, Apold J, Porteous ME, Vasen HF, van Asperen CJ, Moller P.

    J Med Genet. 2009 Sep;46(9):593-7. Epub 2008 Apr 15.PMID: 18413372 [PubMed - in process]Related articles

    18.

    The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.

    Antoniou AC, Cunningham AP, Peto J, Evans DG, Lalloo F, Narod SA, Risch HA, Eyfjord JE, Hopper JL, Southey MC, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tryggvadottir L, Syrjakoski K, Kallioniemi OP, Eerola H, Nevanlinna H, Pharoah PD, Easton DF.

    Br J Cancer. 2008 Apr 22;98(8):1457-66. Epub 2008 Mar 18. Erratum in: Br J Cancer. 2008 Jun 17;98(12):2015. Passini, B [corrected to Pasini, B]. PMID: 18349832 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Probability of BRCA1/2 mutation varies with ovarian histology: results from screening 442 ovarian cancer families.

    Evans DG, Young K, Bulman M, Shenton A, Wallace A, Lalloo F.

    Clin Genet. 2008 Apr;73(4):338-45. Epub 2008 Feb 26.PMID: 18312450 [PubMed - indexed for MEDLINE]Related articles

    20.

    The impact of new screening protocol on individuals at increased risk of colorectal cancer.

    Mak T, Senevrayar K, Lalloo F, Evans DG, Hill J.

    Colorectal Dis. 2007 Sep;9(7):635-40.PMID: 17824981 [PubMed - indexed for MEDLINE]Related articles

    21.

    BRCA1/2 mutation analysis in male breast cancer families from North West England.

    Evans DG, Bulman M, Young K, Howard E, Bayliss S, Wallace A, Lalloo F.

    Fam Cancer. 2008;7(2):113-7. Epub 2007 Jul 17.PMID: 17636422 [PubMed - indexed for MEDLINE]Related articles

    22.

    Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation status.

    Moller P, Evans DG, Reis MM, Gregory H, Anderson E, Maehle L, Lalloo F, Howell A, Apold J, Clark N, Lucassen A, Steel CM.

    Int J Cancer. 2007 Sep 1;121(5):1017-20.PMID: 17471561 [PubMed - indexed for MEDLINE]Related articles

    23.

    Desmoid tumours in patients with familial adenomatous polyposis and desmoid region adenomatous polyposis coli mutations.

    Speake D, Evans DG, Lalloo F, Scott NA, Hill J.

    Br J Surg. 2007 Aug;94(8):1009-13.PMID: 17410559 [PubMed - indexed for MEDLINE]Related articles

    24.

    Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor.

    Ali A, Christie PT, Grigorieva IV, Harding B, Van Esch H, Ahmed SF, Bitner-Glindzicz M, Blind E, Bloch C, Christin P, Clayton P, Gecz J, Gilbert-Dussardier B, Guillen-Navarro E, Hackett A, Halac I, Hendy GN, Lalloo F, Mache CJ, Mughal Z, Ong AC, Rinat C, Shaw N, Smithson SF, Tolmie J, Weill J, Nesbit MA, Thakker RV.

    Hum Mol Genet. 2007 Feb 1;16(3):265-75. Epub 2007 Jan 8.PMID: 17210674 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.

    Antoniou AC, Shenton A, Maher ER, Watson E, Woodward E, Lalloo F, Easton DF, Evans DG.

    Breast Cancer Res. 2006;8(6):R72.PMID: 17187672 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Familial colorectal cancer referral to regional genetics department--a single centre experience.

    Mak T, Speake D, Lalloo F, Hill J, Evans DG.

    Fam Cancer. 2007;6(1):81-7.PMID: 17160434 [PubMed - indexed for MEDLINE]Related articles

    27.

    Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

    Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG.

    J Med Genet. 2007 Jan;44(1):10-15. Epub 2006 Nov 1.PMID: 17079251 [PubMed - indexed for MEDLINE]Related articles

    28.

    Inherited association of breast and colorectal cancer: limited role of CHEK2 compared with high-penetrance genes.

    Naseem H, Boylan J, Speake D, Leask K, Shenton A, Lalloo F, Hill J, Trump D, Evans DG.

    Clin Genet. 2006 Nov;70(5):388-95.PMID: 17026620 [PubMed - indexed for MEDLINE]Related articles

    29.

    Optimal selection of individuals for BRCA mutation testing.

    Evans DG, Lalloo F, Eccles D.

    J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. No abstract available. PMID: 16829657 [PubMed - indexed for MEDLINE]Related articles

    30.

    BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.

    Lalloo F, Varley J, Moran A, Ellis D, O'dair L, Pharoah P, Antoniou A, Hartley R, Shenton A, Seal S, Bulman B, Howell A, Evans DG.

    Eur J Cancer. 2006 May;42(8):1143-50. Epub 2006 Apr 27.PMID: 16644204 [PubMed - indexed for MEDLINE]Related articles

    31.

    Is it time to abandon microsatellite instability as a pre-screen for selecting families for mutation testing for mismatch repair genes?

    Evans GD, Lalloo F, Mak T, Speake D, Hill J.

    J Clin Oncol. 2006 Apr 20;24(12):1960-2; author reply 1962-3. No abstract available. PMID: 16622277 [PubMed - indexed for MEDLINE]Related articles

    32.

    Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.

    Stirling D, Evans DG, Pichert G, Shenton A, Kirk EN, Rimmer S, Steel CM, Lawson S, Busby-Earle RM, Walker J, Lalloo FI, Eccles DM, Lucassen AM, Porteous ME.

    J Clin Oncol. 2005 Aug 20;23(24):5588-96.PMID: 16110018 [PubMed - indexed for MEDLINE]Related articles

    33.

    Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype.

    Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S, Bishop T, Benitez J, Rivas C, Bignon YJ, Chang-Claude J, Hamann U, Cornelisse CJ, Devilee P, Beckmann MW, Nestle-Krämling C, Daly PA, Haites N, Varley J, Lalloo F, Evans G, Maugard C, Meijers-Heijboer H, Klijn JG, Olah E, Gusterson BA, Pilotti S, Radice P, Scherneck S, Sobol H, Jacquemier J, Wagner T, Peto J, Stratton MR, McGuffog L, Easton DF; Breast Cancer Linkage Consortium.

    Clin Cancer Res. 2005 Jul 15;11(14):5175-80.PMID: 16033833 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Surgical decisions made by 158 women with hereditary breast cancer aged <50 years.

    Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, Barr L, Howell A.

    Eur J Surg Oncol. 2005 Dec;31(10):1112-8. Epub 2005 Jul 7.PMID: 16005602 [PubMed - indexed for MEDLINE]Related articles

    35.

    Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies.

    Antoniou AC, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

    J Med Genet. 2005 Jul;42(7):602-3.PMID: 15994883 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Update on the Manchester Scoring System for BRCA1 and BRCA2 testing.

    Evans DG, Lalloo F, Wallace A, Rahman N.

    J Med Genet. 2005 Jul;42(7):e39. No abstract available. PMID: 15994864 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Non-random transmission of mutant alleles to female offspring in BRCA carriers.

    Evans DG, Shenton A, Sharif S, Woodward E, Lalloo F, Maher ER.

    J Med Genet. 2005 Feb;42(2):e6. No abstract available. PMID: 15689441 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer.

    Hopwood P, Howell A, Lalloo F, Evans G.

    Community Genet. 2003;6(4):214-23.PMID: 15331867 [PubMed - indexed for MEDLINE]Related articles

    39.

    Constitutional rearrangements of chromosome 22 as a cause of neurofibromatosis 2.

    Tsilchorozidou T, Menko FH, Lalloo F, Kidd A, De Silva R, Thomas H, Smith P, Malcolmson A, Dore J, Madan K, Brown A, Yovos JG, Tsaligopoulos M, Vogiatzis N, Baser ME, Wallace AJ, Evans DG.

    J Med Genet. 2004 Jul;41(7):529-34. Review. No abstract available. PMID: 15235024 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Molecular stool screening for colorectal cancer.

    Mak T, Lalloo F, Evans DG, Hill J.

    Br J Surg. 2004 Jul;91(7):790-800. Review.PMID: 15227685 [PubMed - indexed for MEDLINE]Related articles

    41.

    A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO.

    Evans DG, Eccles DM, Rahman N, Young K, Bulman M, Amir E, Shenton A, Howell A, Lalloo F.

    J Med Genet. 2004 Jun;41(6):474-80.PMID: 15173236 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    BRCA1/2 predictive testing: a study of uptake in two centres.

    Brooks L, Lennard F, Shenton A, Lalloo F, Ambus I, Ardern-Jones A, Belk R, Kerr B, Craufurd D, Eeles R, Gareth Evans D.

    Eur J Hum Genet. 2004 Aug;12(8):654-62.PMID: 15138457 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.

    Astuti D, Hart-Holden N, Latif F, Lalloo F, Black GC, Lim C, Moran A, Grossman AB, Hodgson SV, Freemont A, Ramsden R, Eng C, Evans DG, Maher ER.

    Clin Endocrinol (Oxf). 2003 Dec;59(6):728-33.PMID: 14974914 [PubMed - indexed for MEDLINE]Related articles

    44.

    Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families.

    Evans DG, Neuhausen SL, Bulman M, Young K, Gokhale D, Lalloo F.

    J Med Genet. 2004 Feb;41(2):e21. No abstract available. PMID: 14757871 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme.

    Amir E, Evans DG, Shenton A, Lalloo F, Moran A, Boggis C, Wilson M, Howell A.

    J Med Genet. 2003 Nov;40(11):807-14.PMID: 14627668 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    High detection rate for BRCA2 mutations in male breast cancer families from North West England.

    Evans DG, Bulman M, Young K, Gokhale D, Lalloo F.

    Fam Cancer. 2001;1(3-4):131-3.PMID: 14574168 [PubMed - indexed for MEDLINE]Related articles

    47.

    Familial breast cancer: an investigation into the outcome of treatment for early stage disease.

    Eccles D, Simmonds P, Goddard J, Coultas M, Hodgson S, Lalloo F, Evans G, Haites N.

    Fam Cancer. 2001;1(2):65-72.PMID: 14573999 [PubMed - indexed for MEDLINE]Related articles

    48.

    Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families.

    Evans DG, Bulman M, Young K, Gokhale D, Lalloo F.

    J Med Genet. 2003 Sep;40(9):e107. No abstract available. PMID: 12960223 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

    Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, Pasini B, Radice P, Manoukian S, Eccles DM, Tang N, Olah E, Anton-Culver H, Warner E, Lubinski J, Gronwald J, Gorski B, Tulinius H, Thorlacius S, Eerola H, Nevanlinna H, Syrjäkoski K, Kallioniemi OP, Thompson D, Evans C, Peto J, Lalloo F, Evans DG, Easton DF.

    Am J Hum Genet. 2003 May;72(5):1117-30. Epub 2003 Apr 3. Erratum in: Am J Hum Genet. 2003 Sep;73(3):709. PMID: 12677558 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.

    Lalloo F, Varley J, Ellis D, Moran A, O'Dair L, Pharoah P, Evans DG; Early Onset Breast Cancer Study Group.

    Lancet. 2003 Mar 29;361(9363):1101-2.PMID: 12672316 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...